Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
zaishengxue
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Zaishengxue is a traditional Chinese medicine (TCM) formulation available as a capsule. It is used primarily in China and appears to be composed of multiple herbal ingredients, though the exact composition is not specified in the available sources. The name "zaishengxue" translates roughly to "regenerate blood," suggesting its use may be related to hematological or supportive therapies, possibly for conditions involving blood deficiency or recovery after illness. There are no details on specific molecular targets, mechanisms of action, or Western pharmacological classification provided in the referenced clinical trial registries[1][3]. No evidence suggests it is a single-molecule pharmaceutical; rather, it fits the profile of a multi-ingredient TCM product.
- Brand names
- zaishengxue
- Other names
- zaishengxue capsule
Beyond the preview
Go deeper on zaishengxue.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on zaishengxue.